COSCIENS Biopharma Inc. (CSCIF) stock
CSCIFOTCPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
$6.49+0.00 (0.00%)
Close on Oct 19, 2026Market cap $24.10MP/E –Yield –
COSCIENS Biopharma free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
COSCIENS Biopharma's free cash flow for the twelve months ending Mar 31, 2026 was -$8.86M. For fiscal 2025 it was -$9.18M. The highest annual figure on record is $6.82M in fiscal 2018.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$9.18M | – |
| FY2024 | Dec 31, 2024 | -$15.73M | – |
| FY2023 | Dec 31, 2023 | -$3.30M | -167.1% |
| FY2022 | Dec 31, 2022 | $4.93M | – |
| FY2021 | Dec 31, 2021 | -$8.61M | -226.3% |
| FY2018 | Dec 31, 2018 | $6.82M | – |
| FY2017 | Dec 31, 2017 | -$22.92M | – |
| FY2016 | Dec 31, 2016 | -$29.08M | – |
| FY2015 | Dec 31, 2015 | -$33.87M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | -$2.18M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.52M | – |
| Q3 FY2025 | Sep 30, 2025 | -$672.00K | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.50M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.50M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.31M | – |
| Q3 FY2024 | Sep 30, 2024 | -$7.91M | -8514.9% |
| Q2 FY2024 | Jun 30, 2024 | -$1.55M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.94M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.67M | -111.0% |
| Q3 FY2023 | Sep 30, 2023 | $94.00K | – |
| Q2 FY2023 | Jun 30, 2023 | -$867.00K | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.06M | – |
| Q4 FY2022 | Dec 31, 2022 | $15.24M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.95M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.89M | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.47M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.42M | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.49M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.64M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.06M | – |
See a number that looks wrong?